Association of sulfotransferase SULT1A1 with breast cancer risk: A meta-analysis of case-control studies with subgroups of ethnic and menopausal statue

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Jiang, Yiwei ^a   Zhou, Liheng ^a   Yan, Tingting ^a   Shen, Zhenzhou ^a   Shao, Zhimin ^a   Lu, Jinsong ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SULFOTRANSFERASE 1A1; ARYL SULFOTRANSFERASE; SULT1A1 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER RISK; DNA POLYMORPHISM; ETHNICITY; HUMAN; MENOPAUSE; PRIORITY JOURNAL; BREAST TUMOR; CASE CONTROL STUDY; CLASSIFICATION; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; META ANALYSIS; POSTMENOPAUSE; PROGNOSIS;

ARYLSULFOTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROGNOSIS;

EID: 77954667307     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-101     Document Type: Article

References (35)

1. Endocrine therapy for breast cancer: an overview. KL Cheung, Breast 2007 16 327 343 10.1016/j.breast.2007.03.004 17499991
2. Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate. LQ Wang MO James, J Steroid Biochem Mol Biol 2005 96 367 374 10.1016/j.jsbmb.2005.05.002 16011896
3. Estrogen Sulfotransferases in Breast and Endometrial Cancers. JR Pasqualini, Ann Ny Acad Sci 2009 1155 88 98 10.1111/j.1749-6632.2009.04113.x 19250196
4. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. T Suzuki T Nakata Y Miki C Kaneko T Moriya T Ishida S Akinaga H Hirakawa M Kimura H Sasano, Cancer Res 2003 63 2762 2770 12782580 (Pubitemid 36667146)
5. Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma. T Suzuki Y Miki T Nakata Y Shiotsu S Akinaga K Inoue T Ishida M Kimura T Moriya H Sasano, J Steroid Biochem Mol Biol 2003 86 449 454 10.1016/S0960-0760(03)00356-X 14623543 (Pubitemid 37412583)
6. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. RB Raftogianis TC Wood DM Otterness JA Van Loon RM Weinshilboum, Biochem Biophys Res Commun 1997 239 298 304 10.1006/bbrc.1997.7466 9345314
7. An investigation of the relationship between SULT1A1 Arg(213)His polymorphism and lung cancer susceptibility in a Turkish population. S Arslan Y Silig H Pinarbasi, Cell Biochem Funct 2009 27 211 215 10.1002/cbf.1558 19350537
8. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia. LF Gulyaeva ON Mikhailova VO PustyInyak IV Kim AV Gerasimov SE Krasilnikov ML Filipenko EV Pechkovsky, Adv Exp Med Biol 2008 617 359 366 full-text 18497059
9. Further evidence for null association of phenol sulfotransferase SULT1A1 polymorphism with prostate cancer risk: a case-control study of familial prostate cancer in a Japanese population. H Koike H Nakazato N Ohtake H Matsui H Okugi Y Shibata S Nakata H Yamanaka K Suzuki, Int Urol Nephrol 2008 40 947 951 10.1007/s11255-008-9364-5 18368507
10. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. LZ Zheng YF Wang MB Schabath HB Grossman XF Wu, Cancer Lett 2003 202 61 69 10.1016/j.canlet.2003.08.007 14643027
11. Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. A Kotnis S Kannan R Sarin R Mulherkar, Br J Cancer 2008 99 1340 1347 10.1038/sj.bjc.6604683 18854828
12. SULT1A1 R213 H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls. Z Wang Y Fu C Tang S Lu WM Chu, Breast Cancer Res Treat 2010 122 1 193 8 Epub 2009 Dec 1 10.1007/s10549-009-0648-y 19949855
13. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. H Li TC Ha BC Tai, Breast 2009 18 183 191 10.1016/j.breast. 2009.03.008 19446452
14. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia. LF Gulyaeva ON Mikhailova VO PustyInyak IV Kim AV Gerasimov SE Krasilnikov ML Filipenko EV Pechkovsky, Adv Exp Med Biol 2008 617 359 366 full-text 18497059
15. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. TR Rebbeck AB Troxel AH Walker S Panossian S Gallagher EG Shatalova R Blanchard S Norman G Bunin A DeMichele M Berlin R Schinnar JA Berlin BL Strom, Cancer Epidemiol Biomarkers Prev 2007 16 444 450 10.1158/1055-9965.EPI-06-0800 17372239
16. Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. ON Mikhailova LF Gulyaeva AV Prudnikov AV Gerasimov SE Krasilnikov, Pharmacogenomics Journal 2006 6 189 193 10.1038/sj.tpj.6500365 16402077
17. Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones. G Yang YT Gao QY Cai XO Shu JR Cheng W Zheng, Breast Cancer Res Tr 2005 94 63 70 10.1007/s10549-005-7280-2 (Pubitemid 41416943)
18. Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. P Sillanpaa V Kataja M Eskelinen VM Kosma M Uusitupa H Vainio K Mitrunen A Hirvonen, Pharmacogenet Genom 2005 15 749 752 10.1097/01.fpc.0000172240.34923.46
19. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. C Lilla A Risch S Kropp J Chang-Claude, Breast Cancer Res 2005 7 229 237 10.1186/bcr976 15743503
20. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. L Le Marchand T Donlon LN Kolonel BE Henderson LR Wilkens, Cancer Epidemiol Biomarkers Prev 2005 14 1998 2003 10.1158/1055-9965.EPI-05-0076 16103451
21. Sulfotransferase1A1 and risk of postmenopausal breast cancer. PL Jerevall A Ahmadi M Bergman O Stal S Wingren, Anticancer Res 2005 25 2515 2517 16080486
22. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. JY Choi KM Lee SK Park DY Noh SH Ahn HW Chung W Han JS Kim SG Shin IJ Jang KY Yoo A Hirvonen D Kang, Cancer Epidemiol Biomarkers Prev 2005 14 1090 1095 10.1158/1055-9965.EPI-04-0688 15894657 (Pubitemid 40656452)
23. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. TC Cheng ST Chen CS Huang YP Fu JC Yu CW Cheng PE Wu CY Shen, Int J Cancer 2005 113 345 353 10.1002/ijc.20630 15455371
24. Genetic variants of the sulfotransferase 1A1 and breast cancer risk. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder G Wolf TC Wascher B Paulweber W Weitzer H Samonigg, Breast Cancer Res Treat 2004 87 19 22 10.1023/B:BREA.0000041574.90735.ea 15377847
25. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. DF Han X Zhou MB Hu CH Wang W Xie XD Tan F Zheng F Liu, Toxicol Lett 2004 150 167 177 10.1016/j.toxlet.2004.01.012 15093672 (Pubitemid 38490524)
26. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. P Chacko B Rajan BS Mathew T Joseph MR Pillai, Breast Cancer 2004 11 380 388 10.1007/BF02968046 15604994
27. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. DL Tang A Rundle L Mooney S Cho F Schnabel A Estabrook A Kelly R Levine H Hibshoosh F Perera, Breast Cancer Res Tr 2003 78 217 222 10.1023/A:1022968303118 (Pubitemid 36433914)
28. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. W Zheng DW Xie JR Cerhan TA Sellers WQ Wen AR Folsom, Cancer Epidem Biomar 2001 10 89 94
29. Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer. P Seth KL Lunetta DW Bell H Gray SM Nasser E Rhei CM Kaelin DJ Iglehart JR Marks JE Garber DA Haber K Polyak, Cancer Res 2000 60 6859 6863 11156380
30. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk, Breast Cancer Res Treat 2010 119 463 474 10.1007/s10549-009-0407-0 19424794
31. Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups. KA Kim SY Lee PW Park JM Ha JY Park, Eur J Clin Pharmacol 2005 61 743 747 10.1007/s00228-005-0989-3 16133548
32. The selective estrogen enzyme modulators in breast cancer: a review. JR Pasqualini, Biochim Biophys Acta 2004 1654 123 143 15172700
33. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. C Carlsten GS Sagoo AJ Frodsham W Burke JP Higgins, Am J Epidemiol 2008 167 759 774 10.1093/aje/kwm383 18270371
34. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. L Adly D Hill ME Sherman SR Sturgeon T Fears C Mies RG Ziegler RN Hoover C Schairer, Int J Cancer 2006 119 2402 2407 10.1002/ijc.22203 16894564
35. Endogenous sex hormones and subsequent breast cancer in premenopausal women. A Micheli P Muti G Secreto V Krogh E Meneghini E Venturelli S Sieri V Pala F Berrino, Int J Cancer 2004 112 312 318 10.1002/ijc.20403 15352045